Arcturus reports promising early results from cystic fibrosis drug trial

Arcturus has announced encouraging early results from its latest drug trial aimed at treating cystic fibrosis, a genetic disorder that affects the lungs and digestive system. This breakthrough could significantly improve the quality of life for patients suffering from this condition, as current treatments often fall short. The positive findings not only highlight the potential of Arcturus's innovative approach but also bring hope to the cystic fibrosis community, which has long awaited more effective therapies.